Literature DB >> 8048967

Dexamethasone suppression of IL-1 beta-induced cyclooxygenase 2 expression is not mediated by lipocortin-1 in A549 cells.

S P Newman1, R J Flower, J D Croxtall.   

Abstract

A549 cells grown under serum free conditions do not express cyclooxygenase 2 (cox 2). However, addition of IL-1 beta results in the induction of cox 2 in a time and dose dependent manner; actinomycin D completely blocks this induction. Dexamethasone completely suppressed the induction of cox 2 only if present during the first 3.5h of IL-1 beta treatment but not if added after 3.5h. Treatment with a neutralising monoclonal antibody (1A, Biogen) specific to lipocortin-1 failed to reverse this inhibition by dexamethasone. However, using this same antibody we were able to reverse completely the effects of dexamethasone on the suppression of PGE2 release. These observations support the idea that glucocorticoids directly regulate cox 2 expression at the transcriptional level and this phenomenon is not mediated by lipocortin-1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8048967     DOI: 10.1006/bbrc.1994.2019

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Importance of interleukin-1 and interleukin-1 receptor antagonist in short-term glucose sensor function in vivo.

Authors:  Ulrike Klueh; Zenghe Liu; Ben Feldman; Don Kreutzer
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  Investigation into the involvement of phospholipases A(2) and MAP kinases in modulation of AA release and cell growth in A549 cells.

Authors:  Q G Choudhury; D T McKay; R J Flower; J D Croxtall
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

3.  Regulation of cyclooxygenase-2 (COX-2) in rat renal cortex by adrenal glucocorticoids and mineralocorticoids.

Authors:  M Z Zhang; R C Harris; J A McKanna
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  Role of interleukin-1/interleukin-1 receptor antagonist family of cytokines in long-term continuous glucose monitoring in vivo.

Authors:  Ulrike Klueh; Omar Antar; Yi Qiao; Donald L Kreutzer
Journal:  J Diabetes Sci Technol       Date:  2013-11-01

5.  Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1.

Authors:  L Minghetti; A Nicolini; E Polazzi; A Greco; M Perretti; L Parente; G Levi
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

6.  Glucocorticoid inhibition of adjuvant arthritis synovial macrophage nitric oxide production: role of lipocortin 1.

Authors:  Y H Yang; P Hutchinson; L L Santos; E F Morand
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

7.  Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells.

Authors:  Jamie D Croxtall; Peter Th W van Hal; Qam Choudhury; Derek W Gilroy; Rod J Flower
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

8.  Modulation of respiratory syncytial virus-induced prostaglandin E2 production by n-3 long-chain polyunsaturated fatty acids in human respiratory epithelium.

Authors:  Dani-Louise Bryan; Prue Hart; Kevin Forsyth; Robert Gibson
Journal:  Lipids       Date:  2005-10       Impact factor: 1.880

9.  Interleukin-1 beta induces expression of cyclooxygenase-2 mRNA in human gingival fibroblasts.

Authors:  T Yucel-Lindberg; H Ahola; S Nilsson; J Carlstedt-Duke; T Modéer
Journal:  Inflammation       Date:  1995-10       Impact factor: 4.092

10.  Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat.

Authors:  C C Wu; J D Croxtall; M Perretti; C E Bryant; C Thiemermann; R J Flower; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.